Skip to content
Review Open access

Ribose-5-Phosphate Isomerase Deficiency: Exploring One of the World’s Rarest Pediatric Metabolic Disorders

Sep 2026 · Advanced International Journal for Research · 0 citations · 5 references

Abstract

Abstract: Ribose-5-Phosphate Isomerase (RPI) Deficiency is an exceptionally rare autosomal recessive genetic disorder caused by mutations in the RPIA gene (Gard, 2026). With only five known cases documented worldwide as of 2025, it is considered one of the rarest human diseases. The disorder impairs the pentose phosphate pathway, resulting in the toxic accumulation of polyols that cause progressive white matter damage in the brain(Huck et al., 2004). Affected children typically experience developmental delay, epilepsy, neurological regression, ataxia, spasticity, optic atrophy, and leukoencephalopathy (Knaap et al., 1999). This review synthesizes current knowledge on the biochemistry, clinical presentation, diagnostic challenges, and prospects of RPI deficiency, highlighting broader implications for rare disease research in pediatrics.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.